A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers. Due to our strong investigator networks throughout India’s competitive clinical landscape, first-hand knowledge of the region, and dedicated project teams, PRA exceeded the planned patient enrollment by 50% and achieve on-time site activation for both studies.

Explore related content and topics